Andrew E. Hendifar, MD, MPH
Andrew E. Hendifar, MD, MPH, is a physician in Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute, which houses a full range of specialty centers to diagnose and treat most forms of cancer.
Dr. Hendifar developed his expertise in oncology research with investigative roles at the Sarcoma Oncology Center in Santa Monica, where he also worked in drug development for pancreatic cancer, and the Division of Oncology at the University of Southern California. At USC, his work included delving into the role of hormone pathways in gastrointestinal carcinogenesis and prognostic markers for response and survival in Stage 2 and 3 colon cancer.
His work has been published in prestigious journals, including Clinical Cancer Research, the Annals of Oncology and the Journal of Gastrointestinal Oncology. Dr. Hendifar has displayed deep subject-matter knowledge in presentations for organizations such as the National Institutes of Health and the American Society of Clinical Oncology.
In addition to his professional work, Dr. Hendifar has given his time and talents to organizations that bring medical services to underserved populations, such as migrant workers in Mexico and the rural communities of Nicaragua. In his previous role, he also volunteered as a facilitator of the Sarcoma Oncology Support Group.
His early research career covered diverse topics at Louisiana State University’s Emergency Medicine Department, the National Institutes of Health and at Tulane University School of Medicine, where he received his medical degree and a Master of Public Health in Health Systems. He completed his residency at USC’s Department of Internal Medicine where he was Chief Resident. He was also a Chief Fellow in the school’s Department of Hematology and Oncology. He earned bachelor’s degrees in philosophy and biochemistry at the University of Maryland.